Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer [0.03%]
替泊替尼治疗MET外显子14跳跃突变型非小细胞肺癌的系列印度患者的疗效分析
Rohini Sebastian,Josh Thomas Georgy,Arun George et al.
Rohini Sebastian et al.
The plethora of targetable variants among non-small cell lung cancers is on the rise, making it one of the most important cancer types in the context of precision oncology. Recently, the MET exon14 skipping mutation has emerged as a novel t...
Clinical outcomes of patients with advanced EGFR mutated nonsquamous cell lung carcinoma treated at a tertiary care hospital [0.03%]
特三级医疗中心收治的EGFR突变型晚期非鳞状细胞肺癌患者的临床转归分析
Faiza Ahmed,Aqsa Amjad,Eman Anwar et al.
Faiza Ahmed et al.
Background: Epidermal growth factor receptor (EGFR)-mutated advanced adenocarcinoma of the lung is among the most prevalent mutation types. The treatment paradigm for this condition is rapidly evolving. This study focuses...
The challenge of chemotherapy-related cognitive impairment: assessing and managing cognitive decline after cancer treatment [0.03%]
化疗相关的认知功能损害的挑战：评估和管理癌症治疗后的认知衰退
Lucas Tadeu Barrak Stangler,Amanda Acioli de Almeida Robatto,Pedro José Galvão Freire et al.
Lucas Tadeu Barrak Stangler et al.
Chemotherapy-related cognitive impairment (CRCI) refers to a decline in cognitive function in patients during and after cancer treatment and is mainly associated with the use of cytotoxic chemotherapy (CT). As CT is still an essential compo...
Sociodemographic factors and treatment effects on quality of life in locally advanced breast cancer: a cross-sectional study [0.03%]
社会人口统计学因素及治疗效果对局部晚期乳腺癌患者生活质量的影响：横断面研究
Sasongko Hadi Priyono,Winardi Budiwinata,Budianto Tedjowitono et al.
Sasongko Hadi Priyono et al.
Purpose: This study aimed to identify key aspects of health-related quality of life in women with locally advanced breast cancer (LABC) and analyse their links to factors and treatment modalities. ...
Time toxicity in cancer treatment: oncologists' knowledge and practices across Pakistan [0.03%]
巴基斯坦各地肿瘤学家对时间毒性癌症治疗的知识和实践调查研究
Muhammad Arif Hameed,Insia Ali,Waqas Ahmed Khan et al.
Muhammad Arif Hameed et al.
Background: Time toxicity refers to the considerable time investment required by patients undergoing cancer treatment, including travel, waiting periods and treatment duration. It is increasingly recognised not only as a ...
A rare case of clear cell Hidradenocarcinoma presenting with recurrent pleural and cardiac effusion [0.03%]
一例以胸腔和心包积液复发表现为特征的透明细胞汗腺癌病例报告
Camilla Engelsmann,Gitte Wooler,Vladimira Horvat et al.
Camilla Engelsmann et al.
Clear cell hidradenocarcinoma (HAC) is a rare and aggressive malignant tumour originating from eccrine sweat glands, accounting for only 0.001% of all tumours. HAC primarily occurs in the head and neck region, with a high propensity for loc...
Vanishing clear cell carcinoma of the kidney presenting with skin metastases - a case report [0.03%]
透明细胞肾癌皮肤转移一例报告
Sidhart Misra,Zainab Yusufali Motiwala,Ayyaz Mulla et al.
Sidhart Misra et al.
Renal cell carcinoma (RCC) is one of the common genitourinary malignancies that has an increasing incidence. RCC presents a diagnostic challenge due to its wide range of clinical manifestations, often leading to delays in diagnosis and comp...
Case Reports
Ecancermedicalscience. 2025 Aug 7:19:1959. DOI:10.3332/ecancer.2025.1959 2025
Cancer burden, its pattern and survival in Muzaffarpur: findings from first population-based cancer registry of Bihar state, India [0.03%]
印度比哈尔邦穆扎法尔普尔人口基于癌症登记处的第一项研究结果：关于癌症负担、分布及生存率的研究
Atul Budukh,Sonali Bagal,Deepak Gupta et al.
Atul Budukh et al.
Background: The first population-based cancer registries (PBCRs) in Bihar state, India was established at Muzaffarpur by the Tata Memorial Centre (TMC), Mumbai. This article presents the cancer burden, its pattern for the...
Treatment outcome in adolescent and young adult acute lymphoblastic leukaemia (ALL) on BFM-95 protocol: experience of a tertiary care Institute from North India [0.03%]
BFM-95方案治疗青少年及年轻成人急性淋巴细胞白血病的疗效分析：印度北部三级医疗机构的经验
Alpika Shukla,Shailendra Prasad Verma,Anil Kumar Tripathi et al.
Alpika Shukla et al.
Background: BFM-95 protocol is among the common regimens used to treat adolescent and young adult (AYA) acute lymphoblastic leukaemia. Five-year survival in AYA patients with acute lymphoblastic leukaemia is inferior when...
Beyond the knife: HDR plesiotherapy brings precision to atypical fibroxanthoma [0.03%]
超越刀片：HDR半物理学治疗不典型纤维黄色瘤带来的精确度
Carmen Saiz,Angel Montero,Mercedes López et al.
Carmen Saiz et al.
Atypical fibroxanthoma is a rare cutaneous tumour of mesenchymal origin, often presenting as a rapidly growing, painless mass in sun-exposed areas. Although historically considered benign, it has an intermediate malignant potential with a r...